These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 5970180

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
    WOEHLER F.
    Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
    [No Abstract] [Full Text] [Related]

  • 4. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD, Muir WA, Kellermeyer RW.
    Crit Rev Clin Lab Sci; 1983 Aug; 19(3):205-66. PubMed ID: 6373141
    [Abstract] [Full Text] [Related]

  • 5. Treatment of iron storage disorders.
    Halliday JW, Bassett ML.
    Drugs; 1980 Sep; 20(3):207-15. PubMed ID: 7428669
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypersiderosis.
    Walsh JR, Mass RE.
    Med Times; 1967 Apr; 95(4):363-9. PubMed ID: 6021601
    [No Abstract] [Full Text] [Related]

  • 8. Alcohol and iron: one glass of red or more?
    Fletcher LM.
    J Gastroenterol Hepatol; 1996 Nov; 11(11):1039-41. PubMed ID: 8985826
    [Abstract] [Full Text] [Related]

  • 9. Transient hepatic deposition of iron im primary hemochromatosis with iron deficiency following venesection.
    Pollycove M, Fawwaz RA, Winchell HS.
    J Nucl Med; 1971 Jan; 12(1):28-30. PubMed ID: 5539902
    [No Abstract] [Full Text] [Related]

  • 10. [Specific treatment of excessive iron deposition in the tissues].
    Plachecka-Gutowska M, Mikolajew M.
    Pol Arch Med Wewn; 1965 Jan; 35(1):111-7. PubMed ID: 5900073
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recent advances in iron metabolism.
    Powell LW, Halliday JW, Bassett ML.
    Aust N Z J Med; 1979 Oct; 9(5):578-83. PubMed ID: 294916
    [No Abstract] [Full Text] [Related]

  • 17. [Contribution to the study of intestinal absorption of inorganic and dietary iron by means of Fe59 in healthy subjects, patients with hemochromatosis and cirrhosis, before and after treatment with Desferal].
    Delaloye B, Magnenat P, Blanc B.
    Nucl Med (Stuttg); 1967 Oct; ():97-111. PubMed ID: 5601765
    [No Abstract] [Full Text] [Related]

  • 18. [Hemosiderosis and idiopathic hemochromatosis].
    Nowotny P.
    Z Gesamte Inn Med; 1967 Dec 15; 22(24):799-806. PubMed ID: 5585476
    [No Abstract] [Full Text] [Related]

  • 19. Liver manganese in hemochromatosis.
    Altstatt LB, Pollack S, Feldman MH, Reba RC, Crosby WH.
    Proc Soc Exp Biol Med; 1967 Feb 15; 124(2):353-5. PubMed ID: 6019870
    [No Abstract] [Full Text] [Related]

  • 20. Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
    Baldus WP, Fairbanks VF, Dickson ER, Baggenstoss AH.
    Mayo Clin Proc; 1978 Mar 15; 53(3):157-65. PubMed ID: 628226
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.